{
 "url": "https://etfiq.com/funds/pth/holdings/",
 "section": "funds",
 "title": "PTH Holdings: All 54 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 54 PTH holdings with weights, as of Oct 13, 2026. The top 3 are IOVA 5.15%, THC 3.87% and NTRA 3.83%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "PTH",
 "fund": "Invesco Dorsey Wright Healthcare Momentum ETF",
 "fund_page": "https://etfiq.com/funds/pth",
 "positions": 54,
 "positions_listed_on_page": 54,
 "lead": "PTH held 54 positions as of Oct 13, 2026. Iovance Biotherapeutics Inc is the largest at 5.15%; the top 10 are 36.6% of the fund.",
 "source": {
  "name": "Invesco",
  "url": "https://dng-api.invesco.com/cache/v1/accounts/en_US/shareclasses/46137V852/holdings/fund?idType=cusip&productType=ETF",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Iovance Biotherapeutics Inc",
   "ticker": "IOVA",
   "weight_pct": 5.148,
   "page": "https://etfiq.com/holdings/iova/"
  },
  {
   "rank": 2,
   "holding": "Tenet Healthcare Corp",
   "ticker": "THC",
   "weight_pct": 3.87,
   "page": "https://etfiq.com/holdings/thc/"
  },
  {
   "rank": 3,
   "holding": "Natera Inc",
   "ticker": "NTRA",
   "weight_pct": 3.831,
   "page": "https://etfiq.com/holdings/ntra/"
  },
  {
   "rank": 4,
   "holding": "Guardant Health Inc",
   "ticker": "GH",
   "weight_pct": 3.688,
   "page": "https://etfiq.com/holdings/gh/"
  },
  {
   "rank": 5,
   "holding": "Revolution Medicines Inc",
   "ticker": "RVMD",
   "weight_pct": 3.688,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 6,
   "holding": "10X Genomics Inc",
   "ticker": "TXG",
   "weight_pct": 3.659,
   "page": "https://etfiq.com/holdings/txg/"
  },
  {
   "rank": 7,
   "holding": "Roivant Sciences Ltd",
   "ticker": "ROIV",
   "weight_pct": 3.579,
   "page": "https://etfiq.com/holdings/roiv/"
  },
  {
   "rank": 8,
   "holding": "Insmed Inc",
   "ticker": "INSM",
   "weight_pct": 3.2,
   "page": "https://etfiq.com/holdings/insm/"
  },
  {
   "rank": 9,
   "holding": "Twist Bioscience Corp",
   "ticker": "TWST",
   "weight_pct": 3.105,
   "page": "https://etfiq.com/holdings/twst/"
  },
  {
   "rank": 10,
   "holding": "Medpace Holdings Inc",
   "ticker": "MEDP",
   "weight_pct": 2.856,
   "page": "https://etfiq.com/holdings/medp/"
  },
  {
   "rank": 11,
   "holding": "Hinge Health Inc",
   "ticker": "HNGE",
   "weight_pct": 2.667,
   "page": "https://etfiq.com/holdings/hnge/"
  },
  {
   "rank": 12,
   "holding": "Illumina Inc",
   "ticker": "ILMN",
   "weight_pct": 2.564,
   "page": "https://etfiq.com/holdings/ilmn/"
  },
  {
   "rank": 13,
   "holding": "Exelixis Inc",
   "ticker": "EXEL",
   "weight_pct": 2.487,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 14,
   "holding": "Protagonist Therapeutics Inc",
   "ticker": "PTGX",
   "weight_pct": 2.345,
   "page": "https://etfiq.com/holdings/ptgx/"
  },
  {
   "rank": 15,
   "holding": "Halozyme Therapeutics Inc",
   "ticker": "HALO",
   "weight_pct": 2.313,
   "page": "https://etfiq.com/holdings/halo/"
  },
  {
   "rank": 16,
   "holding": "Oscar Health Inc",
   "ticker": "OSCR",
   "weight_pct": 2.286,
   "page": "https://etfiq.com/holdings/oscr/"
  },
  {
   "rank": 17,
   "holding": "Charles River Laboratories International Inc",
   "ticker": "CRL",
   "weight_pct": 2.163,
   "page": "https://etfiq.com/holdings/crl/"
  },
  {
   "rank": 18,
   "holding": "Travere Therapeutics Inc",
   "ticker": "TVTX",
   "weight_pct": 2.16,
   "page": "https://etfiq.com/holdings/tvtx/"
  },
  {
   "rank": 19,
   "holding": "Relay Therapeutics Inc",
   "ticker": "RLAY",
   "weight_pct": 2.147,
   "page": "https://etfiq.com/holdings/rlay/"
  },
  {
   "rank": 20,
   "holding": "CareDx Inc",
   "ticker": "CDNA",
   "weight_pct": 2.143,
   "page": "https://etfiq.com/holdings/cdna/"
  },
  {
   "rank": 21,
   "holding": "PACS Group Inc",
   "ticker": "PACS",
   "weight_pct": 2.118,
   "page": "https://etfiq.com/holdings/pacs/"
  },
  {
   "rank": 22,
   "holding": "Axogen Inc",
   "ticker": "AXGN",
   "weight_pct": 2.058,
   "page": "https://etfiq.com/holdings/axgn/"
  },
  {
   "rank": 23,
   "holding": "Kymera Therapeutics Inc",
   "ticker": "KYMR",
   "weight_pct": 1.757,
   "page": "https://etfiq.com/holdings/kymr/"
  },
  {
   "rank": 24,
   "holding": "MBX Biosciences Inc",
   "ticker": "MBX",
   "weight_pct": 1.745,
   "page": "https://etfiq.com/holdings/mbx/"
  },
  {
   "rank": 25,
   "holding": "Dianthus Therapeutics Inc",
   "ticker": "DNTH",
   "weight_pct": 1.732,
   "page": "https://etfiq.com/holdings/dnth/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.001
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/pth/holdings/pth-holdings.csv",
 "json_book": "https://etfiq.com/data/books/pth.json",
 "markdown": "https://etfiq.com/funds/pth/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of PTH, data as of Oct 13, 2026. https://etfiq.com/funds/pth/holdings/"
}